Filing Flows › Comparisons › NXGL vs MDNC
Nexgel vs Medinotec: NXGL and MDNC compared
Nexgel is the larger company: $3.7M of revenue in its latest quarter (Q2 2026) against $3.2M for Medinotec (Q2 FY27). Nexgel is growing faster (+28% against -1% a year earlier). Medinotec is more profitable, with an operating margin of 6.3% against -68.0%.
Where the money goes: NXGL and MDNC
Nexgel (NXGL) · Q2 2026
Nexgel, Q2 2026: revenue $3.7M (+28% year over year), operating margin -68.0%, net loss $3.6M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.
Medinotec (MDNC) · Q2 FY27
Medinotec, Q2 FY27: revenue $3.2M (-1% year over year), operating margin 6.3%, net earnings $41K, operating cash flow $108K. The chart follows the revenue to costs, profit and cash.
| Nexgel (NXGL) | Medinotec (MDNC) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 FY27 |
| Revenue | $3.7M | $3.2M |
| Revenue growth, Y/Y | +28% | -1% |
| Gross margin | — | 48.7% |
| Operating margin | -68.0% | 6.3% |
| Net earnings | −$3.6M | $41K |
| Net margin | -97.8% | 1.3% |
| Operating cash flow | −$2.2M | $108K |
| Free cash flow | — | $61K |
Where the revenue comes from
Medinotec
- Outside the United States: $3.0M (94%)
- Inside U S A Internally Designed Manufactured Sales: $200K (6%)
Questions
Which is bigger, Nexgel or Medinotec?
Nexgel is the larger company: $3.7M of revenue in its latest quarter (Q2 2026) against $3.2M for Medinotec (Q2 FY27).
Is Nexgel or Medinotec growing faster?
Nexgel is growing faster (+28% against -1% a year earlier).
Which is more profitable, Nexgel or Medinotec?
Medinotec is more profitable, with an operating margin of 6.3% against -68.0%.
More: Nexgel earnings · how Nexgel makes money · Medinotec earnings · how Medinotec makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 17, 2026; 10-Q filed Oct 8, 2026). Fiscal quarters can end on different dates. Not investment advice.